depression

Mar 02, 2025

In the contemporary world, major depressive disorder (MDD) is one of the diseases responsible for the greatest healthcare burden. In the United States, more than 24 million people suffer from major depressive disorder each year, while in Europe, about 20 million are diagnosed with the major depressive disorder each...

Feb 21, 2025

Johnson & Johnson’s SPRAVATO, which is already on track to become a blockbuster drug, has received a significant boost with the FDA’s approval for its use as a standalone treatment for major depressive disorder (MDD). Initially approved in 2019, SPRAVATO was authorized for use alongside an oral antidepressant i...

Sep 20, 2023

Sleep Aids Market: Examining Cutting-Edge Technologies and Scientific Breakthroughs Sleep can be burdensome when it disrupts daily routines, requires a significant time commitment, and is marred by sleep disorders or disturbances that affect overall well-being. In today's fast-paced world, where stress, anxiety,...

Jun 06, 2023

FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults Pfizer Inc. announced that the FDA has authorized ABRYSVO (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory...

Aug 03, 2022

As per the latest findings, the prevalence of Mental Health has grown significantly over the past two-three decades. The growth has been registered in almost every country worldwide. People of any age, race, religion or economic status can get mental illnesses. It can severely impact personal and professional life ...

Jun 27, 2022

In the current scenario, with an unabating urge to maintain good mental health, individuals seem quite aware of sanity and are much more likely to talk about it openly. More people are accessing care, which in turn, accounts for a notable rise in the number of cases. However, what is really steering this increase s...

Jun 15, 2022

Over the last decade, various technologies, after being evaluated rigorously, have exhibited competence in treating mental health by becoming an extension of the already present care models. Today, the patient or user can now download a clinical-grade app on the phone, tablet, or computer and use it as a reliable m...

Feb 14, 2022

Treatment-resistant Depression (TRD) typically refers to inadequate response to at least two antidepressant medications used for a sufficient length of time at an adequate dose with an adequate affirmation of treatment adherence. Treatment-resistant Depression is a relatively common occurrence in clinical practice,...

Dec 01, 2021

Mental health services in the new technology-driven world offer so many options. Many of these options are accessible via intuitive apps that are designed to streamline the mental health journey and take most of the guesswork out of finding the expert attention. Most of these apps allow to access the features at an...

Oct 08, 2021

Depression is a mental condition characterized by prolonged series of poor moods, loss of interest and enjoyment in ordinary activities, and low energy, all of which contribute to varying degrees of social and vocational dysfunction. Depression is a chronic condition that affects a person's ability to work, quality...